Paper | Year of publication | Age (years)/sex | Type of surgical approach | Type of implants | Duration of follow-up | Outcomes |
---|---|---|---|---|---|---|
Muhlbauer et al. [6] | 2001 | 54/M | Lateral transfacetal retrovascular approach | Iliac crest bone graft | 6 months | Fully ambulatory with no neurological deficit |
Suchomel et al. [9] | 2013 | 62/M | Transoral and posterior approach | Harms mesh cage | 17 days | No neurodeficit except C2 distribution hypesthesia |
Ortega-Porcayo et al. [5] | 2014 | 43/M 23/F | Extended transoral transmandibular approach and posterior approach | 1. Titanium cage 2. Nonvascularized autologous fibular graft | 2 years | Improved neurological without hardware failure |
Taran et al. [10] | 2015 | 44/F | Transoral endoscopic resection and posterior fixation |  | 3 years | Free from recurrence and no neurological deficit |
Weil et al. [12] | 2015 | 46/F | Transoral transmandibular | Titanium mesh cage | 40 months | Functioning normally, no deficit in speech and swallowing |
Ozpinar et al. [7] | 2016 | 48/F | Midline labiomandibular glossotomy | Expandable cage | 26 months | Disease free without neurologic deficit |
Wewel et al. [13] | 2016 | 35/M | Transoral and posterior approach | Expandable cage | 6 months | Intact neurological status without any significant morbidity |
Tenny et al. [11] | 2017 | 55/F | Anterior transmandibular and posterior approach | Pyrimesh cage | 10 months | Tumor free |
Petrov et al. [8] | 2019 | 27/M | Transoral robotic surgery with a posterior approach | Iliac crest bone graft | 15 months | Disease free |
The present study | Â | 47/F | Transoral transmandibular and posterior approach | Titanium mesh cage | 5Â years | No recurrence without neurological deficit |